A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...
Immunotherapeutic interventions are showing promise in cancer treatment, but challenges like low response rates, off-target delivery, and toxicity still ...
"As we just updated our strategy with a focus on our ANKET platform and ADC programs, this meeting will be an opportunity to share the latest scientific and clinical advancements related to Nectin-4 ...